Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05357066 · ClinicalTrials.gov registry record · Phase 2

Nitrous Oxide as Treatment for Fibromyalgia

A Phase 2 study of Fibromyalgia and Central Neuropathic Pain, sponsored by University of Chicago.

Recruiting
Registry status
Phase 2
Development phase
50
Enrollment target
1
Study location

NCT05357066 is a Phase 2 study of Fibromyalgia and Central Neuropathic Pain that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 50 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05357066, a Phase 2 study of Fibromyalgia and Central Neuropathic Pain, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
Phase 2
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore a potential role of nitrous oxide in treating pain associated with fibromyalgia.

Conditions Studied

Fibromyalgia Central Neuropathic Pain

Interventions

  • DRUG Placebo
  • DRUG Nitrous oxide gas for inhalation

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-11-12
Est. Completion 2027-12-01
Phase Phase 2

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05357066

The ClinicalTrials.gov registry entry for NCT05357066 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (72% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05357066 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05357066 about?

NCT05357066 is a clinical study titled "Nitrous Oxide as Treatment for Fibromyalgia". The purpose of this study is to explore a potential role of nitrous oxide in treating pain associated with fibromyalgia.

What is the current status of trial NCT05357066?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2021-11-12. Estimated completion is 2027-12-01.

What conditions does trial NCT05357066 study?

This clinical trial studies the following conditions: Fibromyalgia, Central Neuropathic Pain.

What interventions are being tested in trial NCT05357066?

The interventions under investigation include: Placebo (DRUG), Nitrous oxide gas for inhalation (DRUG).

Who is sponsoring clinical trial NCT05357066?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05357066 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fibromyalgia

All registered trials for this condition

Central Neuropathic Pain

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.